summary
Introduced
02/01/2017
02/01/2017
In Committee
02/01/2017
02/01/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Medicare Drug Savings Act of 2017 This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan (PDP). Subject to civil monetary penalties, a Medicare or MA PDP sponsor must report, both to drug manufacturers and to the CMS, specified information related to the determination and payment of such rebates.
AI Summary
This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services (CMS) for prescription drugs dispensed to eligible low-income individuals under the Medicare prescription drug benefit or a Medicare Advantage (MA) prescription drug plan. The bill establishes a rebate agreement process and formula for determining the rebate amounts, and imposes reporting requirements and penalties on Medicare Part D plan sponsors for failing to provide the necessary information to CMS and manufacturers.
Committee Categories
Budget and Finance
Sponsors (16)
Bill Nelson (D)*,
Tammy Baldwin (D),
Richard Blumenthal (D),
Sherrod Brown (D),
Dick Durbin (D),
Al Franken (D),
Mazie Hirono (D),
Angus King (I),
Amy Klobuchar (D),
Patrick Leahy (D),
Jack Reed (D),
Bernie Sanders (I),
Jeanne Shaheen (D),
Debbie Stabenow (D),
Tom Udall (D),
Sheldon Whitehouse (D),
Last Action
Read twice and referred to the Committee on Finance. (on 02/01/2017)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/115th-congress/senate-bill/252/all-info |
| BillText | https://www.congress.gov/115/bills/s252/BILLS-115s252is.pdf |
| Bill | https://www.congress.gov/115/bills/s252/BILLS-115s252is.pdf.pdf |
Loading...